Literature DB >> 8229230

Clinical evaluation of interictal fluorine-18-fluorodeoxyglucose PET in partial epilepsy.

T R Henry1, J Engel, J C Mazziotta.   

Abstract

Interictal [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) is useful in presurgical evaluation of medically refractory partial epilepsies. Limited replicability of image interpretation may restrict this application. We investigated interpretation replicability in 241 18F-FDG studies performed with three different tomographs in partial epilepsy patients. Two investigators independently interpreted the studies with a standardized evaluation protocol and without knowledge of the subjects. Replicability of these unbiased interpretations in detection of regional hypometabolism was best for studies performed with the highest performance tomograph. Interictal 18F-FDG studies performed with this tomograph revealed regional hypometabolism in 62% of patients who had normal cerebral magnetic resonance imaging (MRI). Replicability of interpretations in detecting regional hypometabolism was adequate for clinical application of interictal 18F-FDG studies performed with any of the tomographs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229230

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

1.  Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications.

Authors:  Gregory G Brown; Camellia Clark; Thomas T Liu
Journal:  J Int Neuropsychol Soc       Date:  2007-05       Impact factor: 2.892

2.  Name calling in the temporal lobe.

Authors:  Warren T Blume; Brent Hayman-Abello
Journal:  Epilepsy Curr       Date:  2008 Nov-Dec       Impact factor: 7.500

3.  The relevance of interictal rCBF brain SPECT in temporal lobe epilepsy: diagnostical value and effects of spatial resolution.

Authors:  C Menzel; A Hufnagel; F Grünwald; L Pavics; K Reichmann; C E Elger; H J Biersack
Journal:  Ann Nucl Med       Date:  1995-11       Impact factor: 2.668

4.  EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.

Authors:  Andrea Varrone; Susanne Asenbaum; Thierry Vander Borght; Jan Booij; Flavio Nobili; Kjell Någren; Jacques Darcourt; Ozlem L Kapucu; Klaus Tatsch; Peter Bartenstein; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

Review 5.  [Positron emission tomography in neuroscience. An integrative part of clinical diagnostic methods and experimental research].

Authors:  B Schaller
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

6.  Detection of mesial temporal lobe hypoperfusion in patients with temporal lobe epilepsy by use of arterial spin labeled perfusion MR imaging.

Authors:  R L Wolf; D C Alsop; I Levy-Reis; P T Meyer; J A Maldjian; J Gonzalez-Atavales; J A French; A Alavi; J A Detre
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

7.  Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex.

Authors:  S Lamusuo; H M Ruottinen; J Knuuti; R Härkönen; U Ruotsalainen; J Bergman; M Haaparanta; O Solin; E Mervaala; U Nousiainen; S Jääskeläinen; A Ylinen; R Kälviäinen; J K Rinne; M Vapalahti; J O Rinne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-12       Impact factor: 10.154

8.  Functional and structural changes in the memory network associated with left temporal lobe epilepsy.

Authors:  Natalie L Voets; Jane E Adcock; Richard Stacey; Yvonne Hart; Katherine Carpenter; Paul M Matthews; Christian F Beckmann
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

Review 9.  WONOEP appraisal: Molecular and cellular biomarkers for epilepsy.

Authors:  Lauren E Walker; Damir Janigro; Uwe Heinemann; Raili Riikonen; Christophe Bernard; Manisha Patel
Journal:  Epilepsia       Date:  2016-07-04       Impact factor: 5.864

10.  Quantitative analysis of simultaneous EEG features during PET studies for childhood partial epilepsy.

Authors:  Yun Jung Hur; Joon Soo Lee; Jong Doo Lee; Mi Jin Yun; Heung Dong Kim
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.